Cargando…
Successful immunotherapy with matrix metalloproteinase-derived peptides in adjuvant arthritis depends on the timing of peptide administration
We have recently found that matrix metalloproteinases (MMPs) are targets for T-cell and B-cell reactivity in experimental arthritis. In the present article, we investigate whether modulation of MMP-specific T-cell responses could influence the course of adjuvant arthritis (AA). Lewis rats were treat...
Autores principales: | van Bilsen, Jolanda HM, Wagenaar-Hilbers, Josée PA, van der Cammen, Maarten JF, van Dijk, Mariska EA, van Eden, Willem, Wauben, Marca HM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125294/ https://www.ncbi.nlm.nih.gov/pubmed/12106501 http://dx.doi.org/10.1186/ar421 |
Ejemplares similares
-
CD134 as target for specific drug delivery to auto-aggressive CD4(+ )T cells in adjuvant arthritis
por: Boot, Elmieke PJ, et al.
Publicado: (2005) -
Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health
por: Kamphuis, Sylvia, et al.
Publicado: (2006) -
CD4(+) T cell activation promotes the differential release of distinct populations of nanosized vesicles
por: van der Vlist, Els J., et al.
Publicado: (2012) -
The protein structure determines the sensitizing capacity of Brazil nut 2S albumin (Ber e1) in a rat food allergy model
por: Van Bilsen, Jolanda HM, et al.
Publicado: (2013) -
Adjuvants for peptide-based cancer vaccines
por: Khong, Hiep, et al.
Publicado: (2016)